Fidelity Bancshares and Fidelity Bank Reveal Finalized Merger Agreement to Acquire Affinity Bancshares, Inc. and Affinity Bank
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 30 2026
0mins
Should l Buy AFBI?
Source: moomoo
Merger Announcement: Fidelity Bank has announced the execution of a definitive merger agreement to acquire Affinity Bank shares, indicating a strategic expansion.
Acquisition Details: The merger aims to enhance Fidelity Bank's market presence and service offerings by integrating Affinity Bank's operations and customer base.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AFBI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AFBI
About AFBI
Affinity Bancshares, Inc. is the holding company for Affinity Bank (the Bank). The Bank’s business consists primarily of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate loans, commercial and industrial loans and residential real estate loans and, to a lesser extent, construction and land loans and consumer loans. It makes commercial and industrial loans, primarily in its market area, to a variety of professionals, sole proprietorships and small businesses, including dental loans, which are originated throughout the Southeastern United States. It offers a variety of deposit accounts, including checking accounts, savings accounts and certificate of deposit accounts. It gathers deposits nationwide through its virtual bank, FitnessBank, which accepts deposits and provides higher interest rates based on customers meeting certain fitness goals. It offers a limited range of consumer loans.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Merger Investigation: Halper Sadeh LLC is investigating Odyssey Marine Exploration, Inc. (NASDAQ:OMEX) for potential fiduciary duty breaches related to its merger with American Ocean Minerals Corporation, which may adversely affect shareholder rights.
- Shareholder Rights Protection: The merger between Corebridge Financial, Inc. (NYSE:CRBG) and Equitable Holdings, Inc. will result in Corebridge shareholders owning approximately 51% of the combined entity, prompting Halper Sadeh LLC to encourage shareholders to understand their legal rights.
- Cash Acquisition: Affinity Bancshares, Inc. (NASDAQ:AFBI) is being sold to Fidelity BancShares (N.C.), Inc. for $23.00 per share in cash, subject to adjustments based on Affinity's stockholders' equity, with Halper Sadeh LLC seeking increased compensation for shareholders.
- Legal Service Commitment: Halper Sadeh LLC offers legal services on a contingency fee basis, aiming to provide relief for investors affected by securities fraud and corporate misconduct, highlighting its commitment to protecting shareholder interests.
See More
- Merger Investigation Launched: Monteverde Law Firm is investigating McCormick & Company's merger with Unilever's Foods business, with McCormick shareholders expected to own approximately 35% of the combined company post-transaction, which could significantly impact shareholder interests.
- Cash Acquisition Proposal: Affinity Bancshares, Inc. plans to sell to Fidelity Bancshares (N.C.) for $23.00 per share in cash, providing direct cash returns to Affinity shareholders and enhancing the attractiveness of their investment.
- Equity Distribution in Merger: The merger between Corebridge Financial, Inc. and Equitable Holdings, Inc. is expected to result in Corebridge shareholders owning about 51% of the combined entity, which may influence future corporate governance and decision-making processes.
- Commitment to Legal Services: Monteverde Law Firm emphasizes its successful track record in securities class actions, showcasing its expertise in advocating for shareholder rights, aiming to attract more potential clients seeking legal support.
See More
- Legal Investigation Launched: Halper Sadeh LLC is investigating Soleno Therapeutics, Inc. (NASDAQ:SLNO) regarding its sale to Neurocrine Biosciences for $53.00 per share in cash, which may infringe on shareholder rights, prompting shareholders to understand their legal rights and options.
- Complex Transaction Terms: Thermon Group Holdings, Inc. (NYSE:THR) is proposed to be sold to CECO Environmental Corp., where shareholders can choose between $10.00 in cash plus 0.6840 shares of CECO stock, $63.89 per share, or 0.8110 shares of CECO stock, potentially affecting the final returns for shareholders.
- Cash Acquisition Proposal: Affinity Bancshares, Inc. (NASDAQ:AFBI) plans to sell to Fidelity BancShares (N.C.) for $23.00 per share in cash, subject to adjustments based on the adjusted stockholders' equity at closing, adding uncertainty to the transaction.
- Shareholder Rights Protection: Halper Sadeh LLC represents investors globally, seeking increased consideration, additional disclosures, or other relief measures to protect shareholder rights and address potential securities fraud issues.
See More
- Shareholder Compensation Investigation: Monteverde Law Firm is investigating the transaction between Affinity Bancshares, Inc. and Fidelity Bancshares, where Affinity shareholders are expected to receive $23.00 per share in cash, significantly impacting shareholder returns.
- Apellis Pharmaceutical Deal: In the transaction between Apellis Pharmaceuticals, Inc. and Biogen, Apellis shareholders are expected to receive $41.00 per share in cash along with two non-transferable rights of $2.00 each, providing additional potential earnings and enhancing investment appeal.
- Olaplex Acquisition Case: In the deal between Olaplex Holdings, Inc. and Henkel US Operations, Olaplex shareholders are expected to receive $2.06 per share in cash, offering direct cash returns to shareholders and boosting market confidence.
- KORE Group Transaction: In the transaction involving KORE Group Holdings, Inc. and Searchlight Capital Partners, KORE shareholders are expected to receive $9.25 per share in cash, providing substantial cash flow to shareholders and further solidifying their market position.
See More
- Legal Investigation Launched: Halper Sadeh LLC is investigating Soleno Therapeutics, Inc. (NASDAQ:SLNO) regarding its sale to Neurocrine Biosciences for $53.00 per share in cash, which may infringe on shareholder rights.
- Shareholder Rights Protection: Forian Inc. (NASDAQ:FORA) is being acquired by a consortium for $2.17 per share, prompting Halper Sadeh LLC to remind shareholders to consider their legal rights and options.
- Acquisition Terms Review: Affinity Bancshares, Inc. (NASDAQ:AFBI) is selling to Fidelity BancShares (N.C.) for $23.00 per share, with terms subject to adjustment based on adjusted stockholders' equity, necessitating shareholder awareness of potential impacts on their rights.
- Merger Transaction Impact: McCormick & Company, Incorporated (NYSE:MKC) is merging with Unilever's Foods business, resulting in McCormick shareholders owning 35.0% of the combined entity, with Halper Sadeh LLC potentially seeking increased compensation and disclosures for shareholders.
See More
- Soleno Acquisition Investigation: Soleno Therapeutics is set to be acquired by Neurocrine Biosciences for $53.00 per share, totaling approximately $2.9 billion, yet this price is below its 52-week high of $90.32, raising concerns among investors about the board's fiduciary duties.
- Affinity Bancshares Merger Review: Affinity Bancshares will be acquired by Fidelity BancShares for $23.00 per share, with a total transaction value of about $142.8 million, as investigations question whether the board conducted a fair process, potentially impacting shareholder rights.
- Forian Acquisition Scrutiny: Forian will be acquired by an entity affiliated with CEO Max Wygod for $2.17 per share, with investigations focusing on whether the board failed to uphold fiduciary duties, affecting shareholder confidence in the deal.
- Janus Henderson Acquisition Investigation: Janus Henderson is to be acquired by Trian and General Catalyst for $49.00 per share, amounting to approximately $7.4 billion, with investigations examining whether the board ensured fair value for shareholders, which could jeopardize shareholder interests.
See More










